Every investor dreams of buying into a small cap gem right before a buyout announcement sends shares soaring and delivers a money-doubling trade overnight.
I don’t have a crystal ball, but if I had to make a guess I have five top buyout targets that are on the radar of some Wall Street blue chips right now. Each one of these companies is ripe for a takeover.
Where does the Smart Money look for the best biotech stocks? Small- and mid-cap biotechs. They're the ones with the ability to transform the world, and bring investors transformational profits. To get free access to Hilary Kramer's latest report, 3 Biotech Breakthroughs To Bank On, simply tell us where to send it in the box below.